Cas 177948-11-7,(3R)-N(H)-3-(N-methyl-N-[S]-α-methylbenzyl)aminomethylpyrrolidine

177948-11-7

Post Buying Request

Basic information

Product Name: (3R)-N(H)-3-(N-methyl-N-[S]-α-methylbenzyl)aminomethylpyrrolidine
Synonyms: (3R)-N(H)-3-(N-methyl-N-[S]-α-methylbenzyl)aminomethylpyrrolidine
CAS NO:177948-11-7
Molecular Formula:
Molecular Weight: 218.342
EINECS: N/A
Product Categories: N/A
Mol File: 177948-11-7.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (3R)-N(H)-3-(N-methyl-N-[S]-α-methylbenzyl)aminomethylpyrrolidine(CAS DataBase Reference)
NIST Chemistry Reference: (3R)-N(H)-3-(N-methyl-N-[S]-α-methylbenzyl)aminomethylpyrrolidine(177948-11-7)
EPA Substance Registry System: (3R)-N(H)-3-(N-methyl-N-[S]-α-methylbenzyl)aminomethylpyrrolidine(177948-11-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 177948-11-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

177948-11-7 Suppliers

Recommended suppliersmore

177948-11-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 177948-11-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,7,9,4 and 8 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 177948-11:
(8*1)+(7*7)+(6*7)+(5*9)+(4*4)+(3*8)+(2*1)+(1*1)=187
187 % 10 = 7
So 177948-11-7 is a valid CAS Registry Number.

177948-11-7Upstream product

223453-25-6 (3R)-N-tert-Butyloxycarbonyl-3-[N-(S)-α-methylbenzyl-N-methyl]aminomethylpyrrolidine

177948-11-7Downstream Products

200259-80-9 N-Methyl-N-[(3R)-1-(2-(5-bromobenzofuran-3-yl)ethyl)pyrrolidin-3-ylmethyl]-N-[(1S)-1-phenylethyl]amine

177948-11-7Relevant articles and documents

COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISEASES

-

Page/Page column 30-31, (2008/06/13)

This invention relates to CXCR4 inhibitors and their use in treating and/or preventing a variety of angiogenic, microvascular and ocular disorders including primary indications for diabetic retinopathy, macular degeneration (such as wet or neovascular age

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 177948-11-7